Minimal residual disease response with venetoclax monotherapy in relapsed/refractory CLL patients: VENICE I, phase 3b exploratory analysis
Arnon Kater, Panayiotidis Panagiotis,Melih Aktan,Onder Arslan,Fatih Demirkan,Lisbeth Enggaard,Burhan Ferhanoglu,Marcos Gonzalez Diaz,Yair Herishanu,Karin Karlsson,Brian Leber,Marco Montillo,Davide Rossi,Alan Skarbnik,Adrian Tempescul,Patrick Thornton,Mehmet Turgut,Madlaina Breuleux,Abdullah Masud,Brenda Chyla,Stan Fort,Francesco Forconi LEUKEMIA & LYMPHOMA（2020）
AI 理解论文
溯源树
样例
